Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771745 · ClinicalTrials.gov registry record · Phase 4
Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients
A Phase 4 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT00771745 is a Phase 4 study that has completed, run by University of Cincinnati. The registered enrollment target is 11 participants.
The verdict
NCT00771745, a Phase 4 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
To determine how safe and effective giving Thymoglobulin before transplantation to patients who are going to be receiving kidney transplants.
Interventions
- DRUG Thymoglobulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00771745
The ClinicalTrials.gov registry entry for NCT00771745 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thymoglobulin is the first listed.
NCT00771745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00771745 about?
NCT00771745 is a clinical study titled "Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients". To determine how safe and effective giving Thymoglobulin before transplantation to patients who are going to be receiving kidney transplants.
What is the current status of trial NCT00771745?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2008-09. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00771745?
The interventions under investigation include: Thymoglobulin (DRUG).
Who is sponsoring clinical trial NCT00771745?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.